These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22406656

  • 1. Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial.
    Wlodarczyk Z, Ostrowski M, Mourad M, Krämer BK, Abramowicz D, Oppenheimer F, Miller D, Dickinson J, Undre N.
    Ther Drug Monit; 2012 Apr; 34(2):143-7. PubMed ID: 22406656
    [Abstract] [Full Text] [Related]

  • 2. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T, Satoh S, Kagaya H, Numakura K, Inoue T, Saito M, Narita S, Tsuchiya N, Habuchi T, Miura M.
    Transplantation; 2012 Nov 27; 94(10):1013-9. PubMed ID: 23073468
    [Abstract] [Full Text] [Related]

  • 3. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
    Tsuchiya T, Ishida H, Tanabe T, Shimizu T, Honda K, Omoto K, Tanabe K.
    Transplantation; 2013 Jul 27; 96(2):198-204. PubMed ID: 23792649
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    Alloway R, Vanhaecke J, Yonan N, White M, Haddad H, Rábago G, Tymchak W, Diaz Molina B, Grimm M, Eiskjaer H, Karpf C, Undre N.
    J Heart Lung Transplant; 2011 Sep 27; 30(9):1003-10. PubMed ID: 21493098
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J, Van der Walt I, Kallmeyer J, Miller D, Dawood S, Moosa MR, Christiaans M, Karpf C, Undre N.
    Ther Drug Monit; 2012 Feb 27; 34(1):46-52. PubMed ID: 22249344
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation.
    Méndez A, Berastegui C, López-Meseguer M, Monforte V, Bravo C, Blanco A, Camós S, Pou L, Roman A.
    Transplantation; 2014 Feb 15; 97(3):358-62. PubMed ID: 24492423
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F, Debord J, Undre N, Rousseau A, Marquet P.
    Ther Drug Monit; 2010 Apr 15; 32(2):129-35. PubMed ID: 20110850
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial.
    Fischer L, Trunečka P, Gridelli B, Roy A, Vitale A, Valdivieso A, Varo E, Seehofer D, Lynch S, Samuel D, Ericzon BG, Boudjema K, Karpf C, Undre N.
    Liver Transpl; 2011 Feb 15; 17(2):167-77. PubMed ID: 21280190
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J, del Castillo D, Cabello M, Pallardó L, Grinyó JM, Fernández AM, Brunet M.
    Transplantation; 2010 Apr 27; 89(8):994-1000. PubMed ID: 20335831
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study.
    Cabello M, García P, González-Molina M, Díez de los Rios MJ, García-Sáiz M, Gutiérrez C, López V, Sola E, Burgos D, Hernández D.
    Transplant Proc; 2010 Oct 27; 42(8):3038-40. PubMed ID: 20970603
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.
    Pharmacol Res; 2018 Mar 27; 129():84-94. PubMed ID: 29229354
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation.
    Stifft F, Stolk LM, Undre N, van Hooff JP, Christiaans MH.
    Transplantation; 2014 Apr 15; 97(7):775-80. PubMed ID: 24686426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.